Cargando…

Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index

Radiation-induced fibrosis is widely considered as a common but forsaken phenomenon that can lead to clinical sequela and possibly vital impairments. Lysophosphatidic acid is a bioactive lipid involved in fibrosis and probably in radiation-induced fibrosis as suggested in recent studies. Lysophospha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rancoule, Chloé, Espenel, Sophie, Trone, Jane-Chloé, Langrand-Escure, Julien, Vallard, Alexis, Rehailia-Blanchard, Amel, Hamrouni, Anis El Meddeb, Xia, Yaxiong, Guy, Jean-Baptiste, Ben-Mrad, Majed, Magné, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522168/ https://www.ncbi.nlm.nih.gov/pubmed/28402936 http://dx.doi.org/10.18632/oncotarget.16672

Ejemplares similares

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
por: Vallard, Alexis, et al.
Publicado: (2017)

Healing touch in radiation therapy: is the benefit tangible?
por: Guy, Jean-Baptiste, et al.
Publicado: (2017)

Focus on the expected quality of reporting in SBRT/radiosurgery prospective studies: how far have we come in 30 years?
por: Vial, Nicolas, et al.
Publicado: (2021)

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
por: Espenel, Sophie, et al.
Publicado: (2018)

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience
por: Espenel, Sophie, et al.
Publicado: (2018)

CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note
por: Jmour, Omar, et al.
Publicado: (2020)

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?
por: Vallard, Alexis, et al.
Publicado: (2017)

Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker
por: Vallard, Alexis, et al.
Publicado: (2018)

Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review
por: Langrand-Escure, Julien, et al.
Publicado: (2017)

Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey
por: Langrand-Escure, Julien, et al.
Publicado: (2018)

In Vitro Cell Death Determination for Drug Discovery: A Landscape Review of Real Issues
por: Méry, Benoite, et al.
Publicado: (2017)

Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
por: Trone, Jane-Chloe, et al.
Publicado: (2020)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype
por: Plastira, I., et al.
Publicado: (2017)

Pro-fibrotic SNPs
por: Maxmen, Amy
Publicado: (2009)

Lysophosphatidic acid, LPA: a bad boy becomes good
por: Budnik, Lygia T
Publicado: (2003)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
por: Wocławek-Potocka, Izabela, et al.
Publicado: (2014)

Lysophosphatidic acid and its receptors LPA(1) and LPA(3) mediate paclitaxel-induced neuropathic pain in mice
por: Uchida, Hitoshi, et al.
Publicado: (2014)

CREB-dependent LPA-induced signaling initiates a pro-fibrotic feedback loop between small airway basal cells and fibroblasts
por: Nathan, Shyam, et al.
Publicado: (2021)

MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
por: Plastira, Ioanna, et al.
Publicado: (2020)

Extracellular Vesicles from Ocular Melanoma Have Pro-Fibrotic and Pro-Angiogenic Properties on the Tumor Microenvironment
por: Piquet, Léo, et al.
Publicado: (2022)

Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators
por: Moghani, Mona Malekzadeh, et al.
Publicado: (2022)

Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration?
por: Gross, Isabel, et al.
Publicado: (2019)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
por: Balijepalli, Pravita, et al.
Publicado: (2021)

Dual “mAb” HER family blockade in head and neck cancer human cell lines combined with photon therapy
por: Guy, Jean-Baptiste, et al.
Publicado: (2017)

Lysophosphatidic acid receptors LPA(4) and LPA(6) differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes
por: Hata, Erina, et al.
Publicado: (2016)

Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)
por: Park, Eun Young, et al.
Publicado: (2012)

Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2
por: YANG, DEZHI, et al.
Publicado: (2013)

Lysophosphatidic acid (LPA) 18:1 transcriptional regulation of primary human gingival fibroblasts
por: Cerutis, D. Roselyn, et al.
Publicado: (2014)

LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice
por: Wang, Fang, et al.
Publicado: (2020)

Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway
por: Won, Kyung-Jong, et al.
Publicado: (2020)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis
por: Puigdomenech-Poch, Maria, et al.
Publicado: (2021)

A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
por: Su, Pan, et al.
Publicado: (2022)

Lysophosphatidic acid LPA(1) and LPA(3) receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice
por: Ueda, Hiroshi, et al.
Publicado: (2018)

Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6
por: Chryplewicz, Agnieszka, et al.
Publicado: (2019)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
por: Grüneis, Rebecca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_toa0nqvodmn8kb20mdf0m3ml4e